Wei-Sheng Huang

Wei-Sheng Huang, Ph.D., is Co-Founder and Vice President of Chemistry at Theseus Pharmaceuticals. As Director, Discovery Chemistry at ARIAD Pharmaceuticals, where he served for 14 years, Wei-Sheng led the medicinal chemistry team that was the engine behind the discovery of ponatinib, brigatinib and mobocertinib. Previously, as Senior Scientist at UCB Pharma, he focused on discovering sigma receptor agonists and opioid receptor-like-1 antagonists. Wei-Sheng conducted postdoctoral research at University of Virginia and Massachusetts Institute of Technology; he has co-authored over 60 publications in peer-reviewed journals; and is co-inventor of over 30 granted patents or patent applications. Wei-Sheng received his Ph.D. from Shanghai Institute of Organic Chemistry, Chinese Academy of Science and his B.S. from Huazhong University of Science and Technology.